Philippe Erbs

Dr, Transgene SA
Illkirch-graffenstaden, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

In memoriam Robert Drillien (1947-2025)

In memoriam Robert Drillien (1947-2025)

Journal: Virologie (Montrouge, France)

Published: March 06, 2026

Contribution de la levure à la virologie synthétique

Contribution de la levure à la virologie synthétique

Journal: Virologie (Montrouge, France)

Published: December 29, 2025

Contribution of yeast to synthetic virology

Contribution of yeast to synthetic virology

Journal: Virologie (Montrouge, France)

Published: December 29, 2025

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery.

Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic Delivery.

Journal: Cancers

Published: October 28, 2025

Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.

Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses.

Journal: Molecular therapy. Oncology

Published: October 17, 2025

TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma.

TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma.

Journal: Frontiers in microbiology

Published: June 30, 2025

A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 01, 2024

3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding FCU1 gene to exert an efficient anti-tumoral activity.

3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding FCU1 gene to exert an efficient anti-tumoral activity.

Journal: Frontiers in oncology

Published: February 09, 2024

Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity.

Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity.

Journal: Molecular therapy. Oncology

Published: June 28, 2023

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors.

Journal: Molecular therapy oncolytics

Published: April 10, 2023

Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.

Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus.

Journal: Biosensors & bioelectronics

Published: May 12, 2022

Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.

Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination.

Journal: Clinical & translational immunology

Published: April 21, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026